Hetero Drugs - Active Pharmaceutical Ingredients (API), Generic Finished Dosages, Custom Synthesis And Contract Research

Hetero Drugs Ltd, an arm of Hetero Group, is one of the leading global players in the Active Pharmaceutical Ingredients (APIs) manufacturing segment. Based in Hyderabad, India, Hetero Drugs specialises in active pharmaceutical ingredients, generic finished dosages, custom synthesis and contract research for regulated markets. All the products of Hetero Drugs strictly comply with the GMP requirements. The wide product range has established the company as a leading finished dosage manufacturer in the global market.

Established in 1993, Hetero Drugs has grown from strength to strength to become a reliable organisation in developing and commercialising products for a variety of therapeutic categories. Combining its research strengths, quality management system, manufacturing capabilities and human resources, Hetero Drugs well justifies its motto ‘where the future started yesterday.’

Strengthened by its nine manufacturing facilities meeting cGMP and USFDA standards, Hetero Drugs exports its products to more than 80 countries in Asia, Middle East, Eastern Europe and Latin America. The company has successfully gained foothold in major markets of the US, Canada and Europe for several of its APIs.

ACTIVE PHARMACEUTICAL INGREDIENTS (API)

Hetero Drugs is one of the largest manufacturers of all anti-retroviral APIs and finished dosages. The company has emerged as the largest manufacturer of several active pharmaceutical ingredients in therapeutic categories.

Of the nine active pharmaceutical ingredients manufacturing facilities, four active pharmaceutical ingredients plants have been approved by USFDA. The company expects to get the USFDA approval for two more active pharmaceutical ingredients facilities in 2006-07.

GENERIC FINISHED DOSAGES

Hetero Drugs is one of the largest manufacturers of finished dosages, with its finished dosage facility matching the best in the global market. The company’s facility for finished dosages has been approved by the WHO, Geneva. Besides, the approval by several other regulatory authorities stands a testimony of the serious efforts made by the company to ensure global quality practices at every stage.

All the amenities in the generic finished dosages facility are in total compliance with the requirements of quality and integrity of the products. Hetero Drugs has evolved a foolproof system to implement GMP standards in the manufacture of the products ensuring safety, quality and reliability.

CUSTOM SYNTHESIS

Custom synthesis is one more focused segment of Hetero Drugs and the company has been involved in several projects in this area. Hetero Drugs has established world-class facilities for custom synthesis and contract research to develop new chemical entities. The fine chemicals such as pharmaceutical custom synthesis continue to be the major focus area of the company.

CONTRACT RESEARCH

Hetero Drugs plays a key role in the emerging contract research in the global market. Supported by the world-class research centre with 40 laboratories and 150 scientists, the company is well positioned to explore the opportunities in the contract research segment.

By combining its strong IPR skills, manufacturing capacity, large pool of talent and marketing strength, Hetero Drugs aims to become an aggressive player in contract research, the global pharmaceutical market including active pharmaceutical ingredients.

Given its research capabilities, Hetero Drugs has already evolved its strategies and chalked out the future plan with renowned global companies for carrying out the contract research.